Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
Su5rk70sYhhfm32WlMXsb9Udo8kplmNFjka3fudH.png

30.10 - 31.10.2024

Meet MGI at Lab Innovations 2024!

Explore the future of lab tech with MGI at Lab Innovations 2024! See our latest in liquid handling technology and learn how our solutions enhance lab efficiency.

T5861CsYLvEtmup25T3Scvtr6rv706sIKSH4RpAL.png

26.07 - 11.08.2024

MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports

Advanced Sequencing Tech Battles Doping at Paris 2024 Olympics

EvHOhGq6bG0eLlWGbKsQjc2bF8ig81LJ9jbf4wMe.png

18.07.2024

Elite Controllers: Do their genomes hold the key to curing HIV?

South Africa is advancing HIV research using MGI’s sequencing tools to study "HIV elite controllers" - A rare group of individuals whose immune systems can suppress infection. Scientists from the SAMRC and UKZN are revealing the answer to the natural control of HIV infection leading to new therapies and improved health outcomes.

UWtnzW5ocacnW2qhUiwynHs7UVLE4UOImBJixseh.webp

11.07.2024

MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology

MGI Tech and Predica Diagnostics partner to develop affordable targeted RNA sequencing tests for oncology, enhancing early cancer detection and personalized treatment.

r9Nlv3VJP3lGlmjNW6yyz70LMgIzm8mT18Ovt8m6.png

10.07.2024

Discover how to revolutionise NGS in Oncology with MGI at the 7th NHS Oncology Conference

Join MGI Tech at the 7th NHS Oncology Conference in Manchester and discover how our cutting-edge sequencing and automation solutions can empower you to revolutionise NGS in oncology research

rjxfkjBGaLrwSsGKeBZzJQimifntGkuMZdI2PYbG.png

03.07.2024

Two Sequencing Packages Targeting HIV and Mycobacterium Tuberculosis to Combat Infectious Diseases

Explore the impact of TB and HIV co-infection and the latest advancements in combating drug resistance. Discover how MGI's ATOPlex platform and HIV-1 drug resistance sequencing products revolutionize detection and analysis, empowering global public health efforts.